2024-11-0920201396-029610.1111/dth.142052-s2.0-85090459683http://dx.doi.org/10.1111/dth.14205https://hdl.handle.net/20.500.14288/12227Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.DermatologyJournal Article1529-8019567929500001Q111664